Product Categories
| Country: | China |
|---|---|
| Tel: | 025-58851786 |
| Mobile: | +8617714337195 |
| E-mail: | sales@tybiochem.com |
| QQ: | 1647828559 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Encorafenib (LGX818) | C22H27ClFN7O4S | 1269440-17-6 | Details |
| RG 7388 | C31H29Cl2F2N3O4 | 1229705-06-9 | Details |
| CB-839 | C26H24F3N7O3S | 1439399-58-2 | Details |
| PRT062607 acetate | C21H27N9O3 | 1370261-98-5 | Details |
| Afimoxifene | C26H29NO2 | 68392-35-8 | Details |
| 2-(1-(4-(2-(4-Chlorophenoxy)acetyl)piperazin-1-yl)ethyl)-3-(2-ethoxyphenyl)quinazolin-4(3H)-one | C30H31ClN4O4 | 571203-78-6 | Details |
| (7α,17β)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol | C32H47F5O3S | 129453-61-8 | Details |
| Propanamide, 2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]- | C11H11F3N2O4 | 52806-53-8 | Details |
| Canertinib | C24H25ClFN5O3 | 267243-28-7 | Details |
| 4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid | C21H15N3O4 | 201530-41-8 | Details |
| Roscovitine | C19H26N6O | 186692-46-6 | Details |
| 2-Chloro-4-((1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-yl)ethynyl)pyridine | C18H13ClFN3 | 802906-73-6 | Details |
| 3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione | C19H12Cl2N2O2 | 280744-09-4 | Details |
| PF-06840003 | C12H9FN2O2 | 198474-05-4 | Details |
| N-(4-Methyl-3-(1-methyl-7-((6-methylpyridin-3-yl)amino)-2-oxo-1,2-dihydropyrimido[4,5-d]pyrimidin-3(4H)-yl)phenyl)-3-(trifluoromethyl)benzamide | C28H24F3N7O2 | 839706-07-9 | Details |
| N-[6-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]glycylglycyl-L-phenylalanine | C23H28N4O7 | 1599440-15-9 | Details |
| Tert-Butyl 4-(2-(2,6-Dioxopiperidin-3-Yl)-1,3-Dioxoisoindolin-5-Yl)Piperazine-1-Carboxylate | C22H26N4O6 | 2222114-64-7 | Details |
| 1-[(2,5-Dimethylphenyl)methyl]-6-(1-methyl-1H-pyrazol-4-yl)-α-4-pyridinyl-1H-benzimidazole-2-methanol | C26H25N5O | 1515888-53-5 | Details |
| BMS-986205 | C24H24ClFN2O | 1923833-60-6 | Details |
| Ponatinib hydrochloride | C29H28ClF3N6O | 1114544-31-8 | Details |
| Elagolix sodium | C32H29F5N3NaO5 | 832720-36-2 | Details |
| L-Alanine, N-[(S)-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-, 1-methylethyl ester | C21H29N6O5P | 379270-37-8 | Details |
| 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, hydrochloride, hydrate (1:2:1), (6S)- | C10H20ClN3OS | 191217-81-9 | Details |
| 3-(1-Methyl-1H-indol-3-yl)-4-[1-[1-(2-pyridinylmethyl)-4-piperidinyl]-1H-indol-3-yl]-1H-pyrrole-2,5-dione | C32H29N5O2 | 170364-57-5 | Details |
| Isopropyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate | C20H21ClO4 | 49562-28-9 | Details |
| Gemigliptin(2R,3R)-2,3-dihydroxybutanedioate | C22H25F8N5O8 | 1374639-74-3 | Details |
| N-(4-(5-(Dimethylamino)-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)phenyl)-2-methylbenzamide | C27H29N3O2 | 137975-06-5 | Details |
| 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide | C13H13ClN2O | 49843-98-3 | Details |
| 4-[[6-Amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethylbenzonitrile | C20H15BrN6O | 269055-15-4 | Details |
| Levomilnacipran hydrochloride | C15H23ClN2O | 175131-60-9 | Details |
| 6-[(1R)-1-[8-Fluoro-6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-a]pyridin-3-yl]ethyl]-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one | C23H22FN7O3 | 1173699-31-4 | Details |
| (S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine hydrochloride | C18H20ClNOS | 136434-34-9 | Details |
| Aripiprazole lauroxil | C36H51Cl2N3O4 | 1259305-29-7 | Details |
| 4-(2-Ethyl-2-indanyl)imidazole hydrochloride | C14H16N2.HCl | 104075-48-1 | Details |
| N-[5-[[(5-tert-Butyloxazol-2-yl)methyl]thio]thiazol-2-yl]piperidine-4-carboxamide | C17H24N4O2S2 | 345627-80-7 | Details |
| OTSsp167 | C25H28Cl2N4O2 | 1431697-89-0 | Details |
| N-(4-Chloro-2-fluorophenyl)-6,7-dimethoxy-4-quinazolinamine | C16H13ClFN3O2 | 690206-97-4 | Details |
| PD153035 hydrochloride | C16H14BrN3O2.HCl | 183322-45-4 | Details |
| JZL 195 | C24H23N3O5 | 1210004-12-8 | Details |
| Kevetrin Hydrochloride | C5H10ClN3S | 66592-89-0 | Details |
| (2E)-N-(2-Amino-4-fluorophenyl)-3-(1-(3-phenylallyl)-1H-pyrazol-4-yl)acrylamide | C21H19FN4O | 1357389-11-7 | Details |
| JD 5037 | C27H27Cl2N5O3S | 1392116-14-1 | Details |
| N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-4-chlorobenzamide hydrochloride | C14H17ClN2O | 123464-89-1 | Details |
| Isopropyl 4-((5-methoxy-6-((2-methyl-6-(methylsulfonyl)pyridin-3-yl)amino)pyrimidin-4-yl)oxy)piperidine-1-carboxylate | C21H29N5O6S | 897732-93-3 | Details |
| VU 0364770 | C12H9ClN2O | 61350-00-3 | Details |
| GW9508 | C22H21NO3 | 885101-89-3 | Details |
| 2-Piperazinone,1-methyl-3-[2-(4-methylphenyl)-2-oxoethylidene]- | C14H16N2O2 | 178408-16-7 | Details |
| 5-Chloro-2-(2-(2-((3-(Furan-3-Yl)Phenyl)Amino)-2-Oxoethoxy)Acetamido)Benzoic Acid | C21H17ClN2O6 | 1190221-43-2 | Details |
| Triapine | C7H9N5S | 143621-35-6 | Details |
| rel-4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide | C25H19N3O3 | 1127442-82-3 | Details |
| N-((3-Fluoro-2'-methyl-[2,4'-bipyridin]-5-yl)methyl)-9H-carbazole-2-carboxamide | C25H19FN4O | 2036044-77-4 | Details |
| (R)-tert-Butyl (1-((2-((4-(4-morpholino-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl)carbamoyl)pyridin-4-yl)methyl)piperidin-3-yl)carbamate | C33H40N8O4 | 2448173-47-3 | Details |
| 2-Amino-N-(quinolin-8-yl)benzenesulfonamide | C15H13N3O2S | 16082-64-7 | Details |
| TM5275 sodium | C28H29ClN3NaO5 | 1103926-82-4 | Details |
| Quinoxaline, 6-[2-(1,1-dimethylethyl)-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]- | C21H21N5 | 356559-20-1 | Details |
| 4-[4-(4-Fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-5-yl]pyridine | C21H16FN3OS | 152121-47-6 | Details |
| 7-[(2,3-DICHLOROPHENYL)(PYRIDIN-2-YLAMINO)METHYL]QUINOLIN-8-OL | C21H15Cl2N3O | 352693-80-2 | Details |
| p38α inhibitor 3 | C19H20FNO | 260428-69-1 | Details |
| 4-(6-Methoxy-2-naphthyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole | C26H21N3O2S | 948557-43-5 | Details |
| 2-(piperazin-1-yl)quinoline maleate | C17H19N3O4 | 150323-78-7 | Details |
| (E)-3-(4-Bromo-2,5-dimethoxyphenyl)-1-(4-fluorophenyl)prop-2-en-1-one | C17H14BrFO3 | 2641826-39-1 | Details |
| 3-(1-(3-(Dimethylamino)Propyl)-1H-Indol-3-Yl)-4-(1H-Indol-3-Yl)-1H-Pyrrole-2,5-Dione Hydrochloride | C25H25ClN4O2 | 176504-36-2 | Details |
| DC-TEADin02 | C19H17NO2S | 2380228-45-3 | Details |
| 2-Methoxy-N-(2-oxo-3-(propan-2-ylidene)indolin-5-yl)benzenesulfonamide | C18H18N2O4S | 2490311-14-1 | Details |
| 4-[(Benzo[b]thien-3-ylcarbonyl)[2-(4-chlorophenyl)ethyl]amino]-N-(2,4-difluorophenyl)-1-piperidinecarboxamide | C29H26ClF2N3O2S | 1092847-21-6 | Details |
| Moracin C | C19H18O4 | 69120-06-5 | Details |
| 2-((4-(1-(Methyl-11C)-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)quinoline | C25H20N4O | 1292799-56-4 | Details |
| 3-(3,5-dibromo-4-hydroxybenzylidene)-5-iodoindolin-2-one | C15H8Br2INO2 | 220904-83-6 | Details |
| 1,3-Dihydro-3-[(2,4,6-trimethoxyphenyl)methylene]-2H-indol-2-one | C18H17NO4 | 186611-52-9 | Details |
| 2-Naphthalenecarboxylic acid, 3-hydroxy-, 2-[(3,4-dihydroxyphenyl)methylene]hydrazide | C18H14N2O4 | 304448-55-3 | Details |
| N-[(1-Chloro-4-hydroxy-3-isoquinolinyl)carbonyl]glycine | C12H9ClN2O4 | 223387-75-5 | Details |
| N-(2-((3-(4-Bromophenyl)allyl)amino)ethyl)isoquinoline-5-sulfonamide | C20H20BrN3O2S | 127243-85-0 | Details |
| 1-Methyl-N-(2-methyl-4-(o-tolyldiazenyl)phenyl)-1H-pyrazole-5-carboxamide | C19H19N5O | 301326-22-7 | Details |
| D4476 | C23H18N4O3 | 301836-43-1 | Details |
| WH-4-023 | C32H36N6O4 | 837422-57-8 | Details |
| 4-Methyl-2,6-dioxo-5-((5-phenylfuran-2-yl)methylene)-1,2,5,6-tetrahydropyridine-3-carbonitrile | C18H12N2O3 | 591239-68-8 | Details |
| 4-Chloro-2-[[2-(1-naphthalenyloxy)acetyl]amino]benzoic acid | C19H14ClNO4 | 667411-04-3 | Details |
| Liproxstatin-1 | C19H21ClN4 | 950455-15-9 | Details |
| N'-(Pyridin-2-yl)picolinohydrazide | C11H10N4O | 53995-62-3 | Details |
| (E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide hydrate | C24H27ClFN5O3 | 1042385-75-0 | Details |
| 2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-, hydrate (1:1) | C21H17ClF4N4O4 | 1019206-88-2 | Details |
| Canertinib dihydrochloride | C24H27Cl3FN5O3 | 289499-45-2 | Details |
| GLPG-0187 | C29H37N7O5S | 1320346-97-1 | Details |
| NSC 632839 | C21H21NO.ClH | 157654-67-6 | Details |
| L-Leucinamide, N-[(phenylmethoxy)carbonyl]-L-leucyl-N-[(1S)-1-formyl-3-methylbutyl]- | C26H41N3O5 | 133407-82-6 | Details |
| 2-Phenyl-1,2-benzisoselenazol-3(2H)-one | C13H9NOSe | 60940-34-3 | Details |
| 7-(5-Methyl-2-furanyl)-3-[[6-[[[(3S)-tetrahydro-3-furanyl]oxy]methyl]-2-pyridinyl]methyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-5-amine | C20H21N7O3 | 1202402-40-1 | Details |
| 2,3-Bis(amino((2-aminophenyl)thio)methylene)succinonitrile compound with ethanol | C20H22N6OS2 | 1173097-76-1 | Details |
| 2-(4-Morpholinyl)-6-(1-thianthrenyl)-4H-pyran-4-one | C21H17NO3S2 | 587871-26-9 | Details |
| Bafilomycin A1 | C35H58O9 | 88899-55-2 | Details |
| N-[(Phenylmethoxy)carbonyl]-L-valyl-N-[(1S)-3-fluoro-1-(2-methoxy-2-oxoethyl)-2-oxopropyl]-L-alaninamide | C22H30FN3O7 | 187389-52-2 | Details |
| (6R)-3-[(2-chlorophenyl)thio]-5,6-dihydro-4-hydroxy-6-[4-(4-morpholinyl)phenyl]-6-(3-thienyl)-2(1H)-pyridinone | C25H23ClN2O3S2 | 2003234-63-5 | Details |
| Ethylene glycol polymer | (C2H4O)nH2O | 25322-68-3 | Details |
| N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine | C22H24ClFN4O3 | 184475-35-2 | Details |
| cis-Diammine(1,1-cyclobutanedicarboxylato)platinum | C6H12N2O4Pt | 41575-94-4 | Details |
| Cyclo[(2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl], cyclic (3→5)-disulfide | C24H36N4O6S2 | 128517-07-7 | Details |
| Trans-L-Diaminocyclohexane Oxalatoplatinum | C8H12N2O4Pt | 61825-94-3 | Details |
| 3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one | C14H11F3N2OS | 284028-89-3 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 | ||||